Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth
2023-08-01 by Admin
🎉 Exciting Announcement from Cytocast! 🎉
🌟 We are thrilled to announce the successful completion of our second investment round, where we secured a total funding of 1.65 million Euros from industry-leading venture capital firms. We extend a warm welcome to Bonitás, KDT Holding, Fastventures, Futurmed, and ZoirosVentures, who share our vision of advancing the healthcare industry through data-driven medical technology. Join us in celebrating this significant achievement and stay tuned for more updates on shaping the future of drug discovery, personalized treatments, and patient care. 🤝💊
Stay tuned for exciting developments! 💡
Latest News
Last week, we had the pleasure of presenting Cytocast's cutting-edge technology at the 4th Digital Health Summit as the Best Solution in the Digital Therapy category winner.
Cytocast team recently participated in the Hungarian Molecular Life Science Conference held in Eger. The conference...
Cytocast has been accepted to be part of the Central Europe Deeptech Startup Map. We are...
We are participating in the Best of Show Awards at Bio-IT World Expo in Boston...